Pathophysiology and Treatment of Heart Failure with Preserved Ejection Fraction: State of the Art and Prospects for the Future
AUTOR(ES)
Fernandes, Sara Lopes
FONTE
Arq. Bras. Cardiol.
DATA DE PUBLICAÇÃO
14/11/2019
RESUMO
Documentos Relacionados
- Transcatheter Interatrial Shunts for the Treatment of Heart Failure with Preserved Ejection Fraction
- Heart Failure with Mid-Range Ejection Fraction - State of the Art
- Phenotype mapping of heart failure with preserved ejection fraction
- Heart Failure with Preserved Ejection Fraction and COVID-19: a Pernicious Relationship
- Decompensated Heart Failure with Mid-Range Ejection Fraction: Epidemiology and In-Hospital Mortality Risk Factors